CYP2C19 genotyping
PGxSTEMI08
Approved gene_therapy completed
Quick answer
CYP2C19 genotyping for Myocardial Infarction is a Approved program (gene_therapy) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- Myocardial Infarction
- Phase
- Approved
- Modality
- gene_therapy
- Status
- completed